Kohlberg Kravis Roberts & Co’s RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share RCFA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,500
Closed -$4K 263
2022
Q2
$4K Hold
12,500
﹤0.01% 235
2022
Q1
$5K Buy
+12,500
New +$5.97K ﹤0.01% 256

Other funds holding RCFA.WS

Kohlberg Kravis Roberts & Co's RCFA.WS Position: Q3 2022 in Review

Kohlberg Kravis Roberts & Co sold out of RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (RCFA.WS) in Q3 2022, closing a stake of 12,500 shares — an estimated $4K sold.

Kohlberg Kravis Roberts & Co first reported a position in RCFA.WS in Q1 2022 and held it in 2 quarters. The position peaked at $5K in Q1 2022. 34 funds tracked by Wall St. Rank hold RCFA.WS as of Q3 2022.

  • Kohlberg Kravis Roberts & Co reported no remaining RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q3 2022 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 12,500 RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q3 2022, an estimated $4K.
  • Kohlberg Kravis Roberts & Co first reported a position in RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q1 2022 and held it in 2 quarters.
  • Kohlberg Kravis Roberts & Co's RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $5K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q3 2022.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2022, filed 14 Nov 2022.